Weekly Spotlight - 19.12.24

Latest News

Innovative Treatments and Hopeful Advances in IgA Nephropathy Management

IgA nephropathy is a common kidney disease needing better treatments. Current therapies often fail, leading to costly kidney replacement. New research offers hope with innovative drugs and non-invasive tests. International trials are underway, aiming to improve patient outcomes and revise management guidelines. The future looks promising for IgAN care.

Rare Medical Trio: Fabry Disease, IgA Nephropathy, and Crohn Coexistence

A 27-year-old woman with Crohn disease was diagnosed with both Fabry disease and IgA nephropathy. Her symptoms included haematuria and proteinuria. A kidney biopsy confirmed the conditions. This is the first known case of these three diseases coexisting, highlighting the need for thorough diagnostic evaluations.

Non-invasive PET/CT Imaging Revolutionises IgA Nephropathy Monitoring and Care

This study explores a new, non-invasive method for assessing IgA nephropathy using PET/CT imaging. It shows promise in monitoring disease progression without the need for risky biopsies. The technique offers hope for patients, providing a safer way to track their condition and manage their health.

COVID-19 Impact on Kidney Health in IgA Nephropathy Patients

The study by Miao Hui and colleagues found that mild to moderate COVID-19 does not significantly worsen kidney function in IgA nephropathy patients. Most had mild symptoms, and kidney function remained stable. This offers reassurance to patients, especially those with good baseline kidney health.